The primary aim of the MR group is the development and implementation of new methods and sequences in Magnetic Resonance Imaging with a focus on the brain.
Magnetoencephalography (MEG) is a non-invasive measurement for the detection of the tiny magnetic field components originated from the information processes in the living human brain.
The special field of interest of this group is the preclinical and clinical testing of new radiopharmaceuticals for nuclear medicine diagnostics of brain tumors using Positron-Emission-Tomography (PET) and correlation with Magnetic Resonance Imaging (MRI).
